Literature DB >> 6317393

Failure in labelling of red blood cells with 99mTc: interaction between intravenous cannulae and stannous pyrophosphate.

A M Millar, C G Wathen, A L Muir.   

Abstract

The effect of different methods of stannous pyrophosphate (SnPYP) administration on a modified in vivo technique for labelling red blood cells (RBCs) with 99mTc has been studied. Retention of 99mTc in the bloodstream was measured and parallel in vitro RBC labelling experiments were performed. After administration of SnPYP or a mixture of SnPYP and heparin via the metal needles of intravenous cannulae, the mean 30-min retentions of 99mTc were 96.8% (SD 8.6) and 95.3% (SD 12.4) respectively and the mean in vitro labelling efficiencies were 86.9% (SD 5.0) and 81.9% (SD 18.2) respectively. When the SnPYP was administered via teflon cannulae, the mean 30-min retention of 99mTc was 40.0% (SD 16.7) and the in vitro labelling efficiency was 18.7% (SD 27.0). Reduced RBC labelling and rapid clearance of 99mTc from the bloodstream were not explained by adsorption of stannous ion or pyrophosphate onto the teflon cannulae or retention of SnPYP in the cannulae. When labelling RBCs with 99mTc it is important that SnPYP is not injected via a teflon cannula.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317393     DOI: 10.1007/bf00598911

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Standard techniques for the measurement of red-cell and plasma volume. A report by the International Committee for Standardization in Hematology (ICSH): Panel on Diagnostic Applications of Radioisotopes in Haematology.

Authors: 
Journal:  Br J Haematol       Date:  1973-12       Impact factor: 6.998

2.  Re: clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin.

Authors:  P F Angelberger
Journal:  J Nucl Med       Date:  1979-11       Impact factor: 10.057

3.  A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.

Authors:  R J Callahan; J W Froelich; K A McKusick; J Leppo; H W Strauss
Journal:  J Nucl Med       Date:  1982-04       Impact factor: 10.057

4.  Fully automated sectorial equilibrium radionuclide ventriculography. Proposal of a method for routine use: exercise and follow-up.

Authors:  R Standke; G Hör; F D Maul
Journal:  Eur J Nucl Med       Date:  1983

Review 5.  Drug-induced changes in the biologic distribution of radiopharmaceuticals.

Authors:  W B Hladik; K K Nigg; B A Rhodes
Journal:  Semin Nucl Med       Date:  1982-04       Impact factor: 4.446

6.  Cardiac chamber imaging: a comparison of red blood cells labeled with Tc-99m in vitro and in vivo.

Authors:  F N Hegge; G W Hamilton; S M Larson; J L Ritchie; P Richards
Journal:  J Nucl Med       Date:  1978-02       Impact factor: 10.057

7.  Exercise radionuclide ejection fraction: correlation with exercise contrast ventriculography.

Authors:  T J Brady; K Lo; J H Thrall; J A Walton; J F Brymer; B Pitt
Journal:  Radiology       Date:  1979-09       Impact factor: 11.105

8.  Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals.

Authors:  A M Zimmer; D G Pavel
Journal:  J Nucl Med       Date:  1977-12       Impact factor: 10.057

9.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

Authors:  D G Pavel; M Zimmer; V N Patterson
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

10.  Detection and localization of gastrointestinal bleeding using Tc-99m-pyrophosphate in vivo labeled red blood cells.

Authors:  R K Smith; G Arterburn
Journal:  Clin Nucl Med       Date:  1980-02       Impact factor: 7.794

  10 in total
  5 in total

1.  EANM/ESC guidelines for radionuclide imaging of cardiac function.

Authors:  B Hesse; T B Lindhardt; W Acampa; C Anagnostopoulos; J Ballinger; J J Bax; L Edenbrandt; A Flotats; G Germano; T Gmeiner Stopar; P Franken; A Kelion; A Kjaer; D Le Guludec; M Ljungberg; A F Maenhout; C Marcassa; J Marving; F McKiddie; W M Schaefer; L Stegger; R Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04       Impact factor: 9.236

2.  Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations.

Authors:  A S Hambye; R Vandermeiren; A Vervaet; J Vandevivere
Journal:  Eur J Nucl Med       Date:  1995-01

3.  Failure of in vivo labelling of erythrocytes with technetium-99m: it is not Teflon that is the problem but rather the injection technique.

Authors:  K Verbeke; A Verbruggen
Journal:  Eur J Nucl Med       Date:  1997-04

Review 4.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

Review 5.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.